A detailed history of Ipswich Investment Management Co., Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ipswich Investment Management Co., Inc. holds 37,648 shares of ABBV stock, worth $7.43 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
37,648
Previous 37,698 0.13%
Holding current value
$7.43 Million
Previous $6.86 Million 5.93%
% of portfolio
1.55%
Previous 1.65%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $7,739 - $9,038
-50 Reduced 0.13%
37,648 $6.46 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $15,982 - $18,210
-100 Reduced 0.26%
37,698 $6.86 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $80,154 - $92,790
-600 Reduced 1.56%
37,798 $5.63 Million
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $23,851 - $29,682
-180 Reduced 0.47%
38,398 $5.17 Million
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $77,366 - $89,098
535 Added 1.41%
38,578 $6.15 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $1,659 - $1,990
12 Added 0.03%
38,043 $6.15 Million
Q3 2022

Oct 11, 2022

SELL
$134.21 - $153.93 $38,920 - $44,639
-290 Reduced 0.76%
38,031 $5.1 Million
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $284,322 - $361,467
-2,066 Reduced 5.12%
38,321 $5.87 Million
Q1 2022

Apr 12, 2022

BUY
$131.98 - $163.75 $38,274 - $47,487
290 Added 0.72%
40,387 $6.55 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $126,767 - $160,397
1,180 Added 3.03%
40,097 $5.43 Million
Q3 2021

Oct 07, 2021

BUY
$106.4 - $120.78 $12,768 - $14,493
120 Added 0.31%
38,917 $4.2 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $52,605 - $58,605
-500 Reduced 1.27%
38,797 $4.37 Million
Q1 2021

Apr 09, 2021

SELL
$102.3 - $112.62 $20,460 - $22,524
-200 Reduced 0.51%
39,297 $4.25 Million
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $19,076 - $25,754
237 Added 0.6%
39,497 $4.23 Million
Q3 2020

Oct 06, 2020

SELL
$85.91 - $100.83 $15,034 - $17,645
-175 Reduced 0.44%
39,260 $3.44 Million
Q2 2020

Jul 09, 2020

BUY
$73.37 - $98.18 $42,261 - $56,551
576 Added 1.48%
39,435 $3.87 Million
Q1 2020

Apr 09, 2020

BUY
$64.5 - $97.79 $9,933 - $15,059
154 Added 0.4%
38,859 $2.96 Million
Q4 2019

Jan 08, 2020

BUY
$72.13 - $90.25 $66,720 - $83,481
925 Added 2.45%
38,705 $3.43 Million
Q3 2019

Oct 08, 2019

SELL
$62.98 - $75.72 $13,855 - $16,658
-220 Reduced 0.58%
37,780 $2.86 Million
Q2 2019

Jul 11, 2019

BUY
$65.7 - $83.98 $86,395 - $110,433
1,315 Added 3.58%
38,000 $2.76 Million
Q1 2019

Apr 12, 2019

BUY
$77.14 - $90.79 $303,160 - $356,804
3,930 Added 12.0%
36,685 $2.96 Million
Q4 2018

Jan 15, 2019

SELL
$77.85 - $96.01 $9,342 - $11,521
-120 Reduced 0.37%
32,755 $3.02 Million
Q3 2018

Oct 09, 2018

BUY
$88.91 - $98.84 $259,617 - $288,612
2,920 Added 9.75%
32,875 $3.11 Million
Q2 2018

Jul 18, 2018

BUY
$89.78 - $106.23 $2.34 Million - $2.77 Million
26,055 Added 668.08%
29,955 $2.78 Million
Q1 2018

Apr 12, 2018

SELL
$92.01 - $123.21 $46,005 - $61,605
-500 Reduced 11.36%
3,900 $369,000
Q4 2017

Jan 16, 2018

SELL
$89.56 - $98.21 $1,791 - $1,964
-20 Reduced 0.45%
4,400 $426,000
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $308,737 - $394,352
4,420
4,420 $393,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ipswich Investment Management Co., Inc. Portfolio

Follow Ipswich Investment Management Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.